SCHEMBL17486288

SCHEMBL17486288

COc1cc(Br)cnc1-c1ccc2c(c1)C(C)(C)OC2(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1B Q9Y463 2/20 0.34
IDO1 P14902 1/20 0.34
TDO2 P48775 1/20 0.34
PGR P06401 1/20 0.33
MAPT P10636 5/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPK1 P28482 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
HTT P42858 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
KDM4E B2RXH2 2/20 0.32
RAB9A P51151 2/20 0.32
L3MBTL1 Q9Y468 3/20 0.31
ATM Q13315 2/20 0.31
POLB P06746 1/20 0.31
CHEK1 O14757 1/20 0.31
CACNA1B Q00975 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17486283 0.83 IDO1 (0.35) DYRK1BIDO1TDO2MAPTSMN1; SMN2
SCHEMBL17486221 0.81 ALDH1A1 (0.37) PGRMAPTSMN1; SMN2ALDH1A1MAPK1
SCHEMBL20805575 0.81 ALDH1A1 (0.34) DYRK1BPGRMAPTSMN1; SMN2ALDH1A1
SCHEMBL17486285 0.81 HTR2C (0.42) SMN1; SMN2
SCHEMBL17486203 0.79 DGAT1 (0.37)
SCHEMBL17486133 0.77 TDO2 (0.31) TDO2KDM4EL3MBTL1POLB
SCHEMBL17486216 0.75 MAPK1 (0.37) IDO1TDO2PGRMAPTSMN1; SMN2
SCHEMBL22687831 0.71 PDE10A (0.46) DYRK1BIDO1TDO2MAPTSMN1; SMN2
SCHEMBL17486172 0.70 ALOX5AP (0.36) PGR
SCHEMBL17486204 0.68 PDGFRB (0.34) IDO1MAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 DYRK1B 4672/4885IDO1 2782/4885TDO2 2590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.